<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01303107</url>
  </required_header>
  <id_info>
    <org_study_id>CRIST019</org_study_id>
    <nct_id>NCT01303107</nct_id>
  </id_info>
  <brief_title>Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean</brief_title>
  <official_title>A Non-Inferiority Phase 3 Comparative Study Between a Heavy Levobupivacaine in 50% Enantiomeric Excess (Bupivacaine S75:R25) and Heavy Racemic Bupivacaine for Cesarean Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cristália Produtos Químicos Farmacêuticos Ltda.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irmandade da Santa Casa de Misericordia de Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Irmandade da Santa Casa da Misericórdia de Santos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cristália Produtos Químicos Farmacêuticos Ltda.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the mixture of enantiomers of bupivacaine
      (bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the
      racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The enantiomeric mixture of bupivacaine S75:R25 (75% levobupivacaine and 25% bupivacaine) was
      develop to be a safety regional anesthetic in substitution to racemic bupivacaine (S50:R50).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The Sponsor has no interest in continuing the study.
  </why_stopped>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>latency of sensitive block at T6</measure>
    <time_frame>loss of pain in T6</time_frame>
    <description>The anesthesiologist will evaluate the loss of pain to pin-prick in T10.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of the anesthesia</measure>
    <time_frame>recovery of the sensibility</time_frame>
    <description>Time to recover the sensibility due to the anesthetic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of motor block</measure>
    <time_frame>End of motor block</time_frame>
    <description>Evaluated by the Bromage scale after the injection of the anesthetic solution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximal level of the sensitive blockade</measure>
    <time_frame>last level of sensitive blockade</time_frame>
    <description>Evaluation by pin-prick every 2 minutes after the injection of the anesthetic solution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal cardiocirculatory and respiratory parameters</measure>
    <time_frame>During the study</time_frame>
    <description>systolic and diastolic blood pressure (SBP and DBP), heart rate (HR), and oxygen saturation (SpO2) are evaluate during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parturients ambulation</measure>
    <time_frame>regression of the motor blockade</time_frame>
    <description>Will be measured the time that the parturients ambulate, due to de regression of the motor blockade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral pain</measure>
    <time_frame>suture of the peritoneum</time_frame>
    <description>Visceral pain will be assessed at the time of suture of the peritoneum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal repercussions</measure>
    <time_frame>birth of the neonatal</time_frame>
    <description>Evaluation of the Apgar index in the first and fifth minutes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>bupivacaine S50:R50</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 ml subarachnoid block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine S75:R25</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 ml for subarachnoid block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>single dose of 15 mg by a slow injection rate of 1 mL/s</description>
    <arm_group_label>bupivacaine S50:R50</arm_group_label>
    <arm_group_label>bupivacaine S75:R25</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  parturients at term

          -  ASA (American Society of Anesthesiologists) I or ASA II

          -  elective cesarean section with low risk labor

          -  pre-natal follow-up

          -  patient consent

        Exclusion Criteria:

          -  relative or absolute contraindications for spinal anesthesia

          -  history of hypersensitivity to the local anesthetics

          -  use of opioids during labor

          -  labor lasting more than 12 hours or less than 1 hour

          -  complications of pregnancy such as placenta previa, pre-eclampsia or eclampsia;
             maternal-fetal malnutrition;important accidents during pregnancy.

          -  spinal lesions, peripheral neuropathies or any other neurologic disorders that lead to
             changes of sensitivity and/or motricity

          -  decompensated diabetes or hypertension

          -  history of alcohol and/or drug abuse

          -  cardiopathies, especially myocardiopathies and valvulopathies; important cognitive
             changes

          -  changes in safety exams

          -  twin pregnancy;

          -  signs of intrauterine distress, and abnormalities of fetal vitality, prematurity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liga Mathias, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Irmandade da Santa Casa de Misericórdia de São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Irmandade da Santa Casa da Misericórdia de Santos</name>
      <address>
        <city>Santos</city>
        <state>São Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Irmandade da Santa Casa de Misericóridia de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

